Skip to main content
Premium Trial:

Request an Annual Quote

Dana-Farber Receives $16.5M Gift to Establish Proteomics Center; Aims to Improve Mass Specs

NEW YORK, Dec. 9, (GenomeWeb News) - Dana-Farber Cancer Institute received a $16.5 million gift from John "Jack" Blais and Shelley Blais, the largest gift from an individual, the institute said today.

 

The Cancer Institute will use the money to establish the Blais Proteomics Center, a protein research facility to accelerate Dana-Farber scientists' research on developing proteomic techniques. Jarrod Marto, recently recruited to the institute, will direct the new center.

 

The institute will purchase new-generation mass spectrometers, recruit scientists, fund a development program to design and improve mass spectrometry technology, and support efforts to design models for high volume data analysis.

 

Blais, founder and president of Framingham, Mass.-based holding company BlaisCo, has been a Dana-Farber trustee since 2002.

 

In a statement, Blais said protein research has the "potential to unlock the mysteries of cancer."

 

Including this gift, the Blais family has contributed more than $30 million to Dana-Farber to support protein research, such as the High-Tech Multidisciplinary Research Fund.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.